How a Basophil Activation Test Can Quantify Kinase Inhibition
This short video outlines the features and benefits of our InhibiScreen Kinase Inhibitor Assay which was specifically designed and developed to evaluate the efficacy of lipid kinase inhibitors during lead discovery, lead optimization, and pre-clinical development.
Improving the Kinase Inhibitor Development Process
Learn how our InhibiScreen Kinase Inhibitor Assay can be a valuable tool for improving the kinase inhibitor development process.
PI3K Delta Signaling in Rheumatoid Arthritis
Learn more about PI3K inhibitors and the role of PI3K delta signaling in rheumatoid arthritis.
Class IA PI3K Inhibitor Cancer Therapies
Learn more about the various classes and isoforms of PI3K and Class IA PI3K inhibitor cancer therapies helping to improve B cell cancer patient outcomes.
BTK Inhibitors as Cancer Drug Treatments
Learn about BTK signaling and how the use of BTK inhibitors as cancer drug treatments is changing the lives of B cell cancer patients.